MedTrace Logo

Intravesical Natural Baobab Oil in the Management of BCG-induced Lower Urinary Tract Symptoms

NCT01939756 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2013-09-11

No results posted yet for this study

Summary

Baobab oil is often used in traditional medicine as antipyretic, antioxidant, anti-inflammatory, analgesic and antimicrobial. It also regenerates the epithelial tissue in a short time improving tone and elasticity. We want to evaluate the effects of intravesical Baobab oil in patients with BCG-induced lower urinary tract symptoms.

Conditions

  • Superficial Bladder Cancer
  • Lower Urinary Tract Symptoms

Interventions

DEVICE

Intravesical baobab oil

Intravesical baobab oil

Sponsors & Collaborators

  • University of Bari

    collaborator OTHER

  • Savino M. Di Stasi

    lead OTHER

Principal Investigators

  • Savino M Di Stasi, MD, PhD · Tor Vergata University, Rome, Italy

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2013-06-30
Completion
2013-06-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01939756 on ClinicalTrials.gov